Skip to main content
RCEL
NASDAQ Life Sciences

AVITA Medical's Cohealyx Study Slashes Skin Grafting Time by Nearly 20 Days

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$5.1
Mkt Cap
$150.402M
52W Low
$3.22
52W High
$10.29
52W Position info
58% above low
Off High info
50% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

RCEL sits 58% above its 52-week low of $3.22.

Summary

AVITA Medical announced highly positive interim results from its Cohealyx-I multi-center study, showing a statistically superior reduction of nearly 20 days in mean time to skin grafting for full-thickness wounds (13.6 days vs. 33.2 days benchmark, p<0.001). This significant clinical advancement for Cohealyx, a collagen-based dermal matrix, suggests a substantial improvement in wound care efficiency and patient outcomes. For AVITA Medical, a small-cap company that recently disclosed a 'going concern' warning in its 10-K, these strong product development results are highly material, potentially bolstering its commercial viability and long-term financial health. The company plans to present this data and host an analyst webinar, which will be a key event for investors to assess the product's market potential and regulatory path forward.

At the time of this announcement, RCEL was trading at $5.10 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $150.4M. The 52-week trading range was $3.22 to $10.29. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

RCEL - Latest Insights

RCEL
Nov 05, 2026, 4:15 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $17.70
Real-time Price: $16.70 info
Change: -$1.00 (-6%) info
Market Cap: $484.933M info
RCEL
Nov 05, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $17.91
Real-time Price: $16.70 info
Change: -$1.21 (-7%) info
Market Cap: $484.933M info
RCEL
Nov 05, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $16.65
Real-time Price: $16.70 info
Change: +$0.050 (+0.30%) info
Market Cap: $484.933M info
RCEL
Aug 18, 2026, 7:45 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $8.50
Real-time Price: $16.70 info
Change: +$8.20 (+96%) info
Market Cap: $484.933M info
RCEL
Aug 11, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.20
Real-time Price: $16.70 info
Change: +$8.50 (+104%) info
Market Cap: $484.933M info